Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Ann Powles

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Potent 4-aminopiperidine based antimalarial agentsKristin M Brinner, Mary Ann Powles, Dennis M Schmatz, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2012
MK-4815, a potential new oral agent for treatment of malariaMary Ann Powles, John Allocco, Lai Yeung, et al.
Molecular and Biochemical Parasitology|December 6, 2005
Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitorCarmen A Diaz, John Allocco, Mary Ann Powles, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2018
<i>In Vivo</i> Efficacy of Relebactam (MK-7655) in Combination with Imipenem-Cilastatin in Murine Infection ModelsMary Ann Powles, Andrew Galgoci, Andrew Misura, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2011
Efficacy of caspofungin in a juvenile mouse model of central nervous system candidiasisAmy M Flattery, Emily Hickey, Charles J Gill, et al.
Bioorganic & Medicinal Chemistry|September 28, 2016
Scaffold-hopping from xanthines to tricyclic guanines: A case study of dipeptidyl peptidase 4 (DPP4) inhibitorsDmitri A Pissarnitski, Zhiqiang Zhao, David Cole, et al.
ACS Medicinal Chemistry Letters|May 19, 2016
Discovery of Novel Tricyclic Heterocycles as Potent and Selective DPP-4 Inhibitors for the Treatment of Type 2 DiabetesWen-Lian Wu, Jinsong Hao, Martin Domalski, et al.
Journal of the American Chemical Society|May 9, 2008
Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylationCraig A Parish, Scott K Smith, Kathleen Calati, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2016
Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effectsMatthew Lombardo, Kate Bender, Clare London, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 DiabetesLiangqin Guo, Dann L Parker, Yi Zang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Potent 4-aminopiperidine based antimalarial agentsKristin M Brinner, Mary Ann Powles, Dennis M Schmatz, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2012
MK-4815, a potential new oral agent for treatment of malariaMary Ann Powles, John Allocco, Lai Yeung, et al.
Molecular and Biochemical Parasitology|December 6, 2005
Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitorCarmen A Diaz, John Allocco, Mary Ann Powles, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2018
<i>In Vivo</i> Efficacy of Relebactam (MK-7655) in Combination with Imipenem-Cilastatin in Murine Infection ModelsMary Ann Powles, Andrew Galgoci, Andrew Misura, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2011
Efficacy of caspofungin in a juvenile mouse model of central nervous system candidiasisAmy M Flattery, Emily Hickey, Charles J Gill, et al.
Bioorganic & Medicinal Chemistry|September 28, 2016
Scaffold-hopping from xanthines to tricyclic guanines: A case study of dipeptidyl peptidase 4 (DPP4) inhibitorsDmitri A Pissarnitski, Zhiqiang Zhao, David Cole, et al.
ACS Medicinal Chemistry Letters|May 19, 2016
Discovery of Novel Tricyclic Heterocycles as Potent and Selective DPP-4 Inhibitors for the Treatment of Type 2 DiabetesWen-Lian Wu, Jinsong Hao, Martin Domalski, et al.
Journal of the American Chemical Society|May 9, 2008
Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylationCraig A Parish, Scott K Smith, Kathleen Calati, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2016
Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effectsMatthew Lombardo, Kate Bender, Clare London, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 DiabetesLiangqin Guo, Dann L Parker, Yi Zang, et al.
Pageof 2